Vimarsana
Biggest News Aggregation in the World

Page 2 - L Dopa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from L Dopa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In L Dopa Today - Breaking & Trending Today

Novel Levodopa Delivery System Promises Continuous Dosing - Vimarsana News

Novel Levodopa Delivery System Promises Continuous Dosing

Called DopaFuse, the experimental device is designed to deliver the levodopa and carbidopa into the mouth through a micropump within a wearable retainer.

Novel Continuous Infusion System Promising for Parkinson's - Vimarsana News

Novel Continuous Infusion System Promising for Parkinson's

Continuous infusion strategies have long been sought as a method to preserve levodopa efficacy.

Parkinson's Disease: Focus on Hallucinations - Vimarsana News

Parkinson's Disease: Focus on Hallucinations

Patients often hide their hallucinations, which are associated with poor long-term outcomes and a reduced quality of life.

ISS, Glass Lewis, and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split - Vimarsana News

ISS, Glass Lewis, and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split

Acorda Therapeutics, Inc.

Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA Arbitration Case - Vimarsana News

Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA Arbitration Case

Acorda was awarded $15 million plus prejudgment interest of $1.5 million from Alkermes.